1. Home
  2. DGX vs ROIV Comparison

DGX vs ROIV Comparison

Compare DGX & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$189.81

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.93

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGX
ROIV
Founded
1967
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.1B
20.7B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
DGX
ROIV
Price
$189.81
$28.93
Analyst Decision
Buy
Strong Buy
Analyst Count
13
9
Target Price
$214.38
$28.94
AVG Volume (30 Days)
902.3K
4.3M
Earning Date
04-21-2026
05-28-2026
Dividend Yield
1.82%
N/A
EPS Growth
13.78
N/A
EPS
2.24
N/A
Revenue
$11,035,000,000.00
$29,053,000.00
Revenue This Year
$7.53
N/A
Revenue Next Year
$3.77
$744.61
P/E Ratio
$84.62
N/A
Revenue Growth
11.78
N/A
52 Week Low
$164.65
$10.58
52 Week High
$213.50
$30.33

Technical Indicators

Market Signals
Indicator
DGX
ROIV
Relative Strength Index (RSI) 43.18 58.56
Support Level $187.13 $27.00
Resistance Level $191.91 $30.26
Average True Range (ATR) 4.44 0.90
MACD -0.47 0.06
Stochastic Oscillator 19.99 93.47

Price Performance

Historical Comparison
DGX
ROIV

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: